Trial Profile
Dual homing mechanisms of eosinophils to the sputum; only one of which is sensitive for mepolizumab
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Pharmacodynamics
- Acronyms FOOTSTEP
- 07 Jun 2017 New trial record